Renaissance Technologies »

Xilio Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2026-03-31 $417k 50k 8.41

More positions owned by Renaissance Technologies

United Therapeutics Corporation (UTHR)
Palantir Technologies Cl A (PLTR)
Apple (AAPL)
Kinross Gold Corp (KGC)
Micron Technology (MU)
Verisign (VRSN)
Exelixis (EXEL)
Franco-Nevada Corporation (FNV)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Chevron Corporation (CVX)
Roblox Corp Cl A (RBLX)
Carvana Cl A (CVNA)
Wayfair Cl A (W)
Robinhood Mkts Com Cl A (HOOD)

View all positions for Renaissance Technologies

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Sio Capital Management
Vanguard Capital Management
Caligan Partners
Merck & Co
Stonepine Capital Management
Morgan Stanley
Renaissance Technologies
AJU IB Investment
Geode Capital Management
FMR
Vanguard Fiduciary Trust
GSA Capital Partners
Velan Capital Investment Management

View all funds holding Xilio Therapeutics